Study links health screening results to heart and cancer risk
Part of Cancer, Heart & circulation clinical trials.
This study follows people who had a routine health check to learn what increases the risk of heart disease and cancer. Your answers and test results may help doctors better understand risk factors in the Korean population.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 19 years old or older
- Have had a general health screening at Ulsan University Hospital’s health promotion center
- Be willing to join the study
- Sign the consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to better sort people with heart disease into different risk groups. You may be asked for information about your heart condition and related health to help guide future care.
This study looks for new body markers (including possible genetic traits) to better predict who is likely to have future cardiovascular events. Your results could help doctors estimate risk and choose prevention strategies more accurately.
This trial looks at how nutrition affects people with heart and blood vessel conditions. Anyone with cardiovascular disease can join—there are no strict medical rules.
This study looks at how common heart, kidney, and metabolic problems are in Korea by using health insurance records. It will help doctors understand how often these conditions happen together.
This study tracks your health over time through questionnaires and blood tests to catch diseases early. Researchers will follow your health records to see if personalized care recommendations help prevent serious illnesses like heart disease or cancer.
This study collects blood samples and health information over time to improve early detection of diseases. It may help researchers find ways to prevent serious conditions.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.